L’Oncopole is proud to announce, as part of its joint competition with IRICoR, LeadAction-Onco, an investment of $2.4 million over two years, supporting four flagship oncology drug discovery projects in Canada. This important announcement was made on June 4, 2019 by the Minister of the Economy and Innovation Mr. Pierre Fitzgibbon, on the occasion of the opening of the Quebec pavilion at the BIO International Convention, taking place in Philadelphia from June 3 to 6, 2019.
Funding for this competition has been made possible by leading backers: Merck and the FRQS via Oncopole, and the Ministère de l’Économie et de l’Innovation and the federal government via IRICoR.
This competition is fully in line with Oncopole’s innovative approach to federating oncology research players, promoting innovations and optimizing clinical practices for the benefit of patients.
Thanks to this substantial financial support, the 4 selected winners will be able to benefit from infrastructures and targeted, complementary expertise in drug discovery. A great opportunity for these Quebec researchers to significantly accelerate the transformation of their oncology projects.
Press release: https: //bit.ly/2QNAoXk